Adrienne Mendoza is the Chief Operating Officer of BBG Advanced Therapies, a mission-driven, nonprofit organization working to redefine how patients access life-saving cell and gene therapies. She is leading efforts to challenge outdated models and remove the barriers that limit access to these treatments. Under her leadership, the organization developed the world’s first Mobile Leukapheresis Center. This fully integrated, validated platform brings critical cell collection directly to the communities where patients and donors live.

With a background spanning pharmaceutical operations, advanced therapies, quality and regulatory systems, healthcare administration, and systemic change, Adrienne is reshaping how the industry thinks about scalability, infrastructure, and equitable access. Her goal is simple yet urgent: to dismantle logistical barriers and bring cell and gene therapies within reach for more patients, regardless of their geographical location.